Case Number:

IPR2021-00347

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

Alzheon, Inc.

Patent Owner:

Risen (Suzhou) Pharma Tech Co., Ltd.

Tech Center:

1600

1. Filed: December 18, 2020 00:00

   Coverage

   1. March 11, 2024

      Fed. Circ. OKs Boston Drug Developer's Patent Win

      A Boston-area biotech developer that has yet to bring a product to market persuaded the Federal Circuit on Monday to affirm a finding by an administrative patent board last year that stripped a smaller Chinese rival of a patent covering a way of using a type of sulfonic acid to potentially treat Alzheimer's disease.

   3 other articles on this case. View all »

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login